Urine sensors could replace needles for cancer monitoring
NCT ID NCT01693861
First seen Jan 06, 2026 · Last updated Apr 24, 2026 · Updated 14 times
Summary
This study tested a new way to monitor chemotherapy effects in 16 people with advanced colorectal cancer. Instead of repeated blood draws or scans, researchers measured special substances in urine samples collected daily before and after treatment. The goal was to see if these urine markers could track cancer activity non-invasively. The study was small and observational, so it does not prove the method works yet, but it lays groundwork for simpler cancer monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Paul Brousse Hospital
Villejuif, 94807, France
Conditions
Explore the condition pages connected to this study.